Sugammadex versus neostigmine reversal of moderate rocuronium-induced neuromuscular blockade in Korean patients

Korean Journal of Anesthesiology

Volumn 65, Issue 6, 2014, Pages 501-507

  Woo, Tiffany ^a   Kim, Kyo Sang ^b   Shim, Yon Hee ^c   Kim, Mi Kyeong ^d   Yoon, Suk Min ^e   Lim, Young Jin ^f   Yang, Hong Seuk ^g   Phiri, Phillip ^a   Chon, Jin Young ^h  

^a MERCK RESEARCH LABORATORIES   (United States)

^b Hanyang University   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

^d Kyung Hee University College of Medicine   (South Korea)

^e College of Medicine   (South Korea)

^f Seoul National University Hospital   (South Korea)

^g University of Ulsan College of Medicine   (South Korea)

^h The Catholic University of Korea   (South Korea)

Author keywords

Caucasian; Korean; Neostigmine; Neuromuscular blockade; Rocuronium; Sugammadex

Indexed keywords

NEOSTIGMINE; ROCURONIUM; SUGAMMADEX;

ADULT; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; COUGHING; DIZZINESS; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ENDOTRACHEAL INTUBATION; FEMALE; FEVER; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; NEUROMUSCULAR BLOCKING; NEUROMUSCULAR MONITORING; OUTCOME ASSESSMENT; PAIN; POSTOPERATIVE NAUSEA AND VOMITING; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RHINORRHEA; RISK FACTOR; SENSITIVITY ANALYSIS; SINGLE DRUG DOSE; WOUND COMPLICATION;

EID: 84891889204     PISSN: 20056419     EISSN: 20057563     Source Type: Journal    
DOI: 10.4097/kjae.2013.65.6.501     Document Type: Article

References (13)

1. Jones RK, Caldwell JE, Brull SJ, Soto RG. Reversal of profound rocuronium-induced blockade with sugammadex: A randomized comparison with neostigmine. Anesthesiology 2008; 109: 816-824.
2. Murphy GS. Residual neuromuscular blockade: Incidence, assessment, and relevance in the postoperative period. Minerva Anestesiol 2006; 72: 97-109.
3. Plaud B, Debaene B, Donati F, Marty J. Residual paralysis after emergence from anesthesia. Anesthesiology 2010; 112: 1013-1022.
4. Kang SK, Choi YR, Chung CD. The effect of atropine-neostigmine and glycopyrrolate-neostigmine mixture on heart rate. Korean J Anesthesiol 1987; 20: 166-171.
5. Booij LH, de Boer HD, van Egmond J. Reversal agents for nondepolarizing neuromuscular blockade: Reasons for and development of a new concept. Semin Anesth Periop Med Pain 2002; 32: 92-98.
6. Feinberg M. The problems of anticholinergic adverse effects in older patients. Drugs Aging 1993; 3: 335-348.
7. Blobner M, Eriksson LI, Scholz J, Motsch J, Della Rocca G, Prins ME. Reversal of rocuronium-induced neuromuscular blockade with sugammadex compared with neostigmine during sevoflurane anaesthesia: results of a randomized, controlled trial. Eur J Anaesthesiol 2010; 27: 874-881.
8. Lemmens HJ, El-Orbany MI, Berry J, Morte JB Jr, Martin G. Reversal of profound vecuronium-induced neuromuscular block under sevoflurane anesthesia: Sugammadex versus neostigmine. BMC Anesthesiol 2010; 10: 15.
9. Apfel CC, Läärä E, Koivuranta M, Greim CA, Roewer N. Simplified risks score for predicting postoperative nausea and vomiting: Conclusions from cross-validations between two centers. Anesthesiology 1999; 91: 693-700.
10. Dahaba AA, Perelman SI, Moskowitz DM, Bennett HL, Shander A, Xiao Z, et al. Geographic regional differences in rocuronium bromide doseresponse relation and time course of action: An overlooked factor in determining recommended dosage. Anesthesiology 2006; 104: 950-953.
11. Collins LM, Bevan JC, Bevan DR, Villar GCP, Kahwaji R, Smith MF, et al. The prolonged duration of rocuronium in Chinese patients. Anesth Analg 2000; 91: 1526-1530.
12. Fiset P, Donati F, Balendran P, Meistelman C, Lira E, Bevan DR. Vecuronium is more potent in Montreal than in Paris. Can J Anaesth 1991; 38: 717-721.
13. Katz RL, Norman J, Seed RF, Conrad L. A comparison of the effects of suxamethonium and tubocurarine in patients in London and New York. Br J Anaesth 1969; 41: 1041-1047.